Immunovant, Inc. (IMVT) Misses Q3 EPS by 10c

Immunovant, Inc. (NASDAQ: IMVT) reported Q3 EPS of ($0.49), $0.10 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Walmart (WMT) PT Lowered to $115 at Wolfe Research
• Jefferies: 38% of Australian companies beat estimates this season